Understanding ADHD and the Risks of High-Dose Prescription Amphetamines
Understanding ADHD and Psychosis Risk
Attention deficit hyperactivity disorder (ADHD) is commonly treated with high-dose prescription amphetamines. However, a recent study discovered a *significantly increased risk* of new-onset psychosis among young patients using these stimulants. The findings emphasize the need for careful monitoring of side effects in adolescents and teenagers with attention deficit hyperactivity disorder, particularly in relation to their mental health stability.
Monitoring Patient Safety and Adverse Effects
Adverse effects of high-dose stimulants can be concerning. Health professionals should prioritize patient safety and regularly assess psychiatric effects on teenagers undergoing treatment for ADHD. Awareness about potential issues such as mania and other *mental disorders* is crucial in adolescent medicine.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.